Leerink Partnrs Has Positive Outlook for BBIO Q1 Earnings
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Research analysts at Leerink Partnrs increased their Q1 2025 EPS estimates for BridgeBio Pharma in a research note issued to investors on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will earn ($0.69) per share for the quarter, up from their previous […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Research analysts at Leerink Partnrs increased their Q1 2025 EPS estimates for BridgeBio Pharma in a research note issued to investors on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will earn ($0.69) per share for the quarter, up from their previous […]